Table of Contents
1 Table Of Contents 2 1.1 List of Tables 6 1.2 List of Figures 8 2
Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015 9
2.1 Executive Summary 9 3 Cardiac Assist Devices:Role in Treating Heart
Failure 10 3.1 Overview 10 3.1.1 Pathogenesis of Heart Failure 10
3.1.2 Role of Cardiac Assist Devices 10 3.2 Timeline 11 3.3 Market
Segmentation 11 4 Global Cardiac Assist Devices Market 13 4.1 Cardiac
Assist Devices Market Sizing 13 4.2 Cardiac Assist Devices Market Volume
15 4.3 Cardiac Assist Devices Country Comparison 16 4.3.1 US To Remain
Key Region in the Future 17 4.3.2 Growth Opportunities Outside the US
18 4.4 Cardiac Assist Devices Market Dynamics 19 4.4.1 Market Drivers
19 4.4.1.1 Large patient population 19 4.4.1.2 Fulfilling the Unmet
Need 19 4.4.1.3 Rising Prescription Rates due to Reduced Risks and
Increasing Lifespan 19 4.4.2 Market Restraints 19 4.4.2.1 Long
Development Time and Clinical Risks 19 4.4.2.2 Low Awareness and
Availability in the Developing Economies 19 5 Competitive Landscape 20
5.1 Thoratec Corporation 20 5.1.1 Key Takeaway 20 5.2 Abiomed 21
5.2.1 Overview 21 5.2.1 Key Takeaway 21 5.3 SynCardia Systems, Inc
21 5.3.1 Overview 21 5.3.2 CardioWest temporary Total Artificial Heart
– First Movers Advantage 22 5.3.3 Key Takeaway 22 5.4 Berlin
Heart, Inc. 22 5.4.1 Overview 22 5.4.2 EXCOR - Leading Therapy Option
in Children 22 5.4.3 Key Takeaway 23 6 Cardiac Assist Devices Pipeline
Product Landscape 24 6.1 Overview 24 6.2 Cardiac Assist Devices
Pipeline Product Analysis 26 6.2.1 Stage I: Meeting Patient Demand 27
6.2.2 Stage II: Effective Clinical Trial Information 27 6.2.3 Stage III:
First Movers Advantage 27 6.3 Key Pipeline Product Description 28
6.3.1 AbioCor II 28 6.3.1.1 Product Status 28 6.3.1.2 Product
Description 28 6.3.1.3 Product Patent Details 29 6.3.2 Cardiac Assist
Devices Heartmate II (DT) 30 6.3.2.1 Product Status 30 6.3.2.2 Product
Description 30 6.3.2.3 Heartmate II (DT) Clinical Trial 1 31 6.3.2.4
Heartmate II (DT) Clinical Trial 2 31 6.3.2.5 Heartmate II (DT) Clinical
Trial 3 32 6.3.2.6 Heartmate II (DT) Clinical Trial 4 33 6.3.2.7
Product Patent Details 34 6.3.3 VentrAssist BTT 35 6.3.3.1 Product
Status 35 6.3.3.2 Product Description 35 6.3.3.3 VentrAssist BTT
Clinical Trial 1 36 6.3.3.4 VentrAssist BTT Clinical Trial 2 37
6.3.3.5 entrAssist BTT Clinical Trial 3 38 6.3.3.6 VentrAssist BTT
Clinical Trial 4 39 6.3.3.7 VentrAssist BTT Clinical Trial 5 39 6.3.4
Pediatric M-Pump 39 6.3.4.1 Product Status 39 6.3.4.2 Product
Description 40 7 New Entrants: Promising Products to Intensify Competition
41 7.1 Ventracor as an Acquisition Target 41 8 Pipeline Product
Summary 42 9 Clinical Trial Summary 44 10 Appendix 48 10.1
Definitions 48 10.1.1 Cardiac Assist Devices 48 10.1.2 Intra-Aortic
Balloon Pump Catheters 48 10.1.3 Total Artificial Heart 48 10.1.4
Ventricular Assist Devices 48 10.2 Company Information 49 10.2.1
Thoratec Corporation, Company Revenue 49 10.2.2 Thoratec Corporation, Key
Events 50 10.2.2.1 Thoratec to Acquire HeartWare International 50
10.2.3 HeartMate II – Bridging the Gap between BTT and DT 50 10.2.4
Abiomed Inc., Company Revenues 51 10.2.5 Impella 2.5 Micro Heart Pump
– Providing Competition to IABP 52 10.2.6 Key Strength: Only Total
Artificial Heart On The Market 52 10.3 Research Methodology 53 10.4
Coverage 54 10.5 Secondary Research 54 10.6 Primary Research 55
10.7 Models 55 10.8 Forecasts 56 10.9 Expert Panels 56 10.10
GlobalData Consulting 56 10.11 Contact Us 57 10.12 Disclaimer 57
1.1 List of Tables Table 1: Cardiac Assist Devices Market, Revenue by
Segment ($ m), 2001 – 2008 13 Table 2: Cardiac Assist Devices
Market, Revenue by Segment ($m), 2008 – 2015 14 Table 3: Cardiac
Assist Devices Market, Volume (Units), 2001 – 2008 15 Table 4:
Cardiac Assist Devices Market, Volume (Units), 2008 – 2015 15 Table
5: Cardiac Assist Devices, Revenue By Country ($m), 2001 - 2008 17 Table
6: Cardiac Assist Devices, Revenue By Country ($m), 2008 - 2015 17 Table
7: US Cardiac Assist Devices Market Analysis, 2008 17 Table 8: Key Players
in the Cardiac Assist Devices Market 20 Table 9: Cardiac Assist Devices,
Pipeline Products by Category and Development Stage, 2009 24 Table 10:
AbioCor II, Product Status 28 Table 11: AbioCor II, Product
Description 28 Table 12: AbioCor II Patent Details 29 Table 13:
Heartmate II (DT), Product Status 30 Table 14: Heartmate II (DT),
Product Description 30 Table 15: Heartmate II (DT) - Clinical
Experience With Sternotomy Versus Subcostal Approach for Exchange of the
HeartMate XVE to the HeartMate II Ventricular Assist Device 31 Table 16:
Heartmate II (DT) - Fibrinolytic activation during long-term support with
the HeartMate II left ventricular assist device. 31 Table 17:
Heartmate II (DT) - Initial clinical experience with the HeartMate II
axial-flow left ventricular assist device. 32 Table 18: Heartmate II
(DT) - The HeartMate II LVAS Pivotal Study Protocol, Destination Therapy
33 Table 19: Heartmate II (DT) Patent Details 34 Table 20:
VentrAssist BTT, Product Status 35 Table 21: VentrAssist BTT, Product
Description 35 Table 22: VentrAssist BTT - Evaluation of the
VentrAssist Left Ventricular Assist Device as a Bridge to Cardiac
Transplantation - Feasibility Trial 36 Table 23: VentrAssist BTT -
Evaluation of the VentrAssist Left Ventricular Assist Device as a Bridge to
Cardiac Transplantation - Pivotal Trial 37 Table 24: VentrAssist BTT
- VentrAssist (BTT) - Pilot Trial 38 Table 25: VentrAssist BTT -
VentrAssist (BTT) - CE Mark Trial 39 Table 26: VentrAssist BTT -
VentrAssist (BTT) - BRACE Trial 39 Table 27: Pediatric M-Pump,
Product Status 39 Table 28: Pediatric M-Pump, Product Description
40 Table 29: Cardiac Assist Device Pipeline Products 42 Table 30:
Cardiac Assist Devices Clinical Trials 44 Table 31: Thoratec Corporation,
Revenues ($m), 2006 – 2008 49 Table 32: HeartWare International,
Pipeline Product Portfolio 50 Table 33: Abiomed Inc., Revenues ($m), 2005
– 2009 52 1.2 List of Figures Figure 1: History of Cardiac
Assist Devices 11 Figure 2: Types of Cardiac Assist Devices 12 Figure
3: Cardiac Assist Devices Market, Revenue by Segment ($ m), 2001 – 2008
13 Figure 4: Cardiac Assist Devices Market, Revenue by Segment ($m), 2008
– 2015 14 Figure 5: Cardiac Assist Devices, Revenue By Country ($
m), 2008 and 2015 16 Figure 6: Cardiac Assist Devices, Pipeline Products
by Category and Development Stage, 2009 24 Figure 7: Pipeline Product
Comparison, Cardiac Assist Devices Market, 2009 26 Figure 8: Thoratec
Corporation, Revenues ($m), 2006 – 2008 49 Figure 9: Abiomed Inc.,
Revenues ($m), 2005 – 2009 51 Figure 10: GlobalData Methodology
53
|
Related Report
|